Consistent bone marrow-derived cell mobilization following repeated short courses of granulocytecolony-stimulating factor in patients with amyotrophic lateral sclerosis: Results from a multicenter prospective trial

Cytotherapy

Volumn 12, Issue 1, 2010, Pages 50-59

  Tarella, Corrado ^a   Rutella, Sergio ^b   Gualandi, Francesca ^c   Melazzini, Mario ^d   Scimè, Rosanna ^e   Petrini, Mario ^f   Moglia, Cristina ^g   Ulla, Marco ^a   Omedé, Paola ^h   Bella, Vincenzo La ⁱ   Corbo, Massimo ^j   Silani, Vincenzo ^k   Siciliano, Gabriele ^f   Mora, Gabriele ^d   Caponnetto, Claudia ^c   Sabatelli, Mario ^b   Chiò, Adriano ^g  

^a Dipto di Med e Oncol Sperimentale   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d IRCCS   (Italy)

^e VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g SCDU Neurologia i   (Italy)

^h AOS Giovanni B   (Italy)

ⁱ UNIVERSITY OF PALERMO   (Italy)

^j Centro Clinico NEMO   (Italy)

^k ISTITUTO AUXOLOGICO ITALIANO   (Italy)

more..

Author keywords

Amyotrophic lateral sclerosis; Bone marrow derived stem cells; Granulocytecolony stimulating factor; Mobilization

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR4; GRANULOCYTE COLONY STIMULATING FACTOR; MANNITOL; MYELOSTIM; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTHENIA; BONE MARROW CELL; BONE PAIN; CD34 SELECTION; CLINICAL ARTICLE; CLONOGENIC ASSAY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DRUG SAFETY; FATALITY; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; FLU LIKE SYNDROME; HEADACHE; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROLACTINOMA; STEM CELL; STEM CELL MOBILIZATION; TREATMENT REFUSAL;

EID: 75449087365     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653240903300682     Document Type: Article

References (55)

1. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330:585-589
2. Bromberg MB. Quality of life in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am 2008;19:591-605.
3. Brooks BR. Managing amyotrophic lateral sclerosis: slowing disease progression and improving patient quality of life. Ann Neurol 2009;65(Suppl 1):S17-23.
4. Deda H, Inci MC, Kurekci AE, Sav A, Kayihan K, Ozgun E, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cells transplantation: a 1-year follow-up. Cytotherapy 2009;11: 18-25.
5. Martinez HR, Gonzalez-Garza MT, Moreno-Cuevas JE, et al. Stem cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009;11:26-34.
6. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 2000;164:247-256
7. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:64-70.
8. Shyu WC, Lin SZ, Lee CC, et al. Granulocyte colonystimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 2006;174:927-933
9. Sprigg N, Bath PM, Zhao L, et al. Granulocyte-colonystimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 2006; 37:2979-2983
10. Morizane A, Li JY, Brundin P. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res 2008;331:323-336
11. Mezey E, Chandross KJ. Bone marrow: a possible alternative source of cells in the adult nervous system. Eur J Pharmacol 2000;405:297-302.
12. Corti S, Locatelli F, Strazzer S, et al. Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Exp Neurol 2002;177:443-452
13. Garbuzova-Davis S, Willing AE, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003; 12:255-270
14. Mezey E. Bone marrow-derived stem cells in neurological diseases: stones or masons? Regen Med 2007;2:37-49.
15. Sheridan WP, Begley CG, Juttner C. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992;i: 640-644
16. Gianni AM, Siena S, Bregni M, et al. Granulocyte- macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet 1989;ii:580-585
17. Schmitz N, Linch DC, Dreger P, et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 1996;347:353-357
18. Tarella C, Ferrero D, Bregni M, et al. Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. Eur J Cancer 1991;27:22-27
19. Hartmann O, Le Corroller AG, Blaise D, et al. Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphoma: hematologic recovery and cost. Ann Intern Med 1997;126:600-607
20. Zhao LR, Berra HH, Duan WM, et al. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 2007;38:2804-2811
21. Hennemann B, Ickenstein G, Sauerbruch S, et al. Mobilization of CD34+ hematopoietic cells, colony-forming cells and long-term culture-initiating cells into the peripheral blood of patients with an acute cerebral ischemic insult. Cytotherapy 2008;10:303-311
22. Solaroglu I, Cahill J, Tsubokawa T, Beskonakli E, Zhang JH. Granulocyte colony-stimulating factor protects the brain against experimental stroke via inhibition of apoptosis and inflammation. Neurol Res 2009;31(2):167-172
23. Sevimli S, Diederich K, Strecker JK, et al. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol 2009 [Epub ahead of print].
24. Pitzer C, Kruger C, Plaas C, et al. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 2008;131:3335-3347
25. Zhang Y, Wang L, Fu Y, et al. Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;4:1-2.
26. Brooks BR. El Escorial WFN criteria for the diagnosis of ALS. J Neurol Sci 1994;124(Suppl):96-107.
27. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147
28. Swash M, Desai J. Motor neuron disease: classification and nomenclature. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:105-112
29. Rosen AD. Amyotrophic lateral sclerosis. Clinical features and prognosis. Arch Neurol 1978;35:638-642
30. Tyler HR, Shefner J. Amyotrophic lateral sclerosis. In: Delong JM. Handbook of Clinical Neurology, Vol.15, Disease of the Motor System. Elsevier Science Publishers BV; 1991. p. 169-215.
31. Corradini P, Tarella C, Olivieri A, et al. Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. Blood 2002;99:75-82.
32. Gaia S, Smedile A, Omede P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cell mobilization in patients with end stage liver disease. J Hepatol 2006;45:13-19.
33. Tarella C, Zallio F, Caracciolo D, et al. Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells 1999;17:55-61.
34. Handgretinger R, Gordon PR, Leimig T, et al. Biology and plasticity of CD133+ hematopoietic stem cells. Ann NY Acad Sci 2003;996:141-151
35. Potgens AJ, Schmitz U, Kaufmann P, Frank HG. Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows cross reactivity with cytokeratin 18. J Histochem Cytochem 2002;50:1131-1134
36. Kucia M, Ratajczak J, Reca R, et al. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis 2004;32:52-57
37. Ratajczak MZ, Kucia M, Reca R, et al. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 2004;18:29-40.
38. Takahashi T, Masuda H. Ischemia and cytokine induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438 (Pubitemid 29180584)
39. Tarella C, Gavarotti P, Caracciolo D et al. Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rate in poor risk lymphomas. Ann Oncol 1995;6(Suppl 4):3-8.
40. Maurer MH, Schabitz WR, Schneider A. Old friends in new constellations: the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases. Curr Med Chem 2008;15:1407-1411
41. Six I, Gasan G, Mura E, Bordet R. Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia. Eur J Pharmacol 2003;458:327-328
42. Schneider A, Kruger C, Steigleder T, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005;115:2083-2120
43. Solaroglu I, Jadhav V, Zhang JH. Neuroprotective effect of G-CSF. Frontiers Biosci 2007;12:712-724
44. Park HK, Chu K, Lee ST, et al. Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage. Brain Res 2005;1041:125-131
45. Komine-Kobayashi M, Zhang N, Liu M, et al. Neuroprotective effect of recombinant human granulocyte colonystimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 2006;26:402-413
46. Schabitz WR, Kollmar R, Schwaninger M, et al. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 2003;34:745-751
47. Tanaka M, Kikuchi H, et al. Intrathecal upregulation of G-CSF and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006;65:816-825
48. Tarella C, Caracciolo D, Gavarotti P, et al. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant 1995;16:223-228
49. Akard LP, Wiemann M, Thompson JM, et al. Impaired stem cell collection by consecutive courses of high-dose mobilizing chemotherapy using cyclophosphamide, etoposide, and G-CSF. J Hematother 1996;5:271-277
50. Padovan CS, Jahn K, Birnbaum T, et al. Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant 2003;12:839-848
51. Porat Y, Porozov S, Belkin D, et al. Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages. Br J Haematol 2006;135:703-714
52. Pruszak J, Sonntag KC, Aung MH, et al. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 2007;25:2257-2268
53. Zangiacomi V, Balon N, Maddens S, et al. Cord bloodderived neurons are originated from CD133+/CD34 stem/ progenitor cells in a cell-to-cell contact dependent manner. Stem Cells Dev 2008;17:1005-1016
54. Kuci S, Kuci Z, Schmid S, et al. Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif 2008;41:12-27.
55. Cashman N, Tan LY, Krieger C, et al. Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve 2008;37:620-625